Vivicells International Stock Analysis
| VCII Stock | USD 0.0001 0.00 0.00% |
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta 44.401 |
ViviCells International holds a debt-to-equity ratio of 1.071. As of now, ViviCells International's Debt To Assets are decreasing as compared to previous years. The ViviCells International's current Total Debt To Capitalization is estimated to increase to 0.21, while Long Term Debt is projected to decrease to under 2.2 M. With a high degree of financial leverage come high-interest payments, which usually reduce ViviCells International's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
ViviCells International's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. ViviCells International's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps ViviCells Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect ViviCells International's stakeholders.
For many companies, including ViviCells International, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for ViviCells International, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, ViviCells International's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
The current Total Stockholder Equity is estimated to decrease to about 1.3 M. The current Common Stock is estimated to decrease to about 75.4 K. The current Price To Sales Ratio is estimated to decrease to about 17.1 K. The current Price Earnings Ratio is estimated to decrease to -767.34. ViviCells International is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of ViviCells International stock analysis is to determine its intrinsic value, which is an estimate of what ViviCells International is worth, separate from its market price. There are two main types of ViviCells International's stock analysis: fundamental analysis and technical analysis.
The ViviCells International stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ViviCells International's ongoing operational relationships across important fundamental and technical indicators.
ViviCells | Build AI portfolio with ViviCells Stock |
ViviCells Stock Analysis Notes
The company had not issued any dividends in recent years. ViviCells International had 1:140 split on the 9th of May 2008. ViviCells International, Inc. operates as a stem cell preservation company. The company was incorporated in 1995 and is based in Evanston, Illinois. VIVICELLS INTERNATIONAL operates under UtilitiesRenewable classification in the United States and is traded on PNK Exchange. It employs 16 people. For more information please call Kenneth Wulwick at 504-241-4400 or visit https://www.vivicells.com.ViviCells International Quarterly Total Revenue |
|
ViviCells International Investment Alerts
| ViviCells International generated a negative expected return over the last 90 days | |
| ViviCells International has some characteristics of a very speculative penny stock | |
| ViviCells International has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 3.77 M. Net Loss for the year was (14.44 K) with profit before overhead, payroll, taxes, and interest of 1.13 M. | |
| ViviCells International currently holds about 10.26 K in cash with (1.21 M) of positive cash flow from operations. | |
| ViviCells International has a very weak financial position based on the latest SEC disclosures |
ViviCells Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 23.39 K.ViviCells Profitablity
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.46 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.46.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Management Efficiency
The current Return On Tangible Assets is estimated to decrease to -0.0077. The current Return On Capital Employed is estimated to decrease to -0.0069. The ViviCells International's current Debt To Assets is estimated to increase to 0.19, while Total Assets are projected to decrease to under 4.9 M. ViviCells International's management efficiency ratios could be used to measure how well ViviCells International manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.01 | 0.01 | |
| Tangible Book Value Per Share | 0.01 | 0.01 | |
| Enterprise Value Over EBITDA | (949.57) | (902.10) | |
| Price Book Value Ratio | 6.84 | 6.49 | |
| Enterprise Value Multiple | (949.57) | (902.10) | |
| Price Fair Value | 6.84 | 6.49 | |
| Enterprise Value | 4.9 M | 4.7 M |
The operational strategies employed by ViviCells International management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of ViviCells International, as well as the relationship between them.ViviCells International Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Moving Average is predictive technique used to analyze ViviCells International price data points by creating a series of averages of different subsets of ViviCells International entire price series.
ViviCells International Outstanding Bonds
ViviCells International issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ViviCells International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ViviCells bonds can be classified according to their maturity, which is the date when ViviCells International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| VMWARE INC 39 Corp BondUS928563AC98 | View | |
| VMW 22 15 AUG 31 Corp BondUS928563AL97 | View | |
| VODAFONE GROUP PLC Corp BondUS92857WAB63 | View | |
| VMW 14 15 AUG 26 Corp BondUS928563AJ42 | View | |
| VMW 18 15 AUG 28 Corp BondUS928563AK15 | View | |
| VMWARE INC Corp BondUS928563AF20 | View | |
| VODAFONE GROUP PLC Corp BondUS92857WAQ33 | View | |
| VODAFONE GROUP PLC Corp BondUS92857WBM10 | View |
ViviCells International Bond Ratings
ViviCells International financial ratings play a critical role in determining how much ViviCells International have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ViviCells International's borrowing costs.| Piotroski F Score | 1 | Very Weak | View |
| Beneish M Score | (0.43) | Possible Manipulator | View |
ViviCells International Debt to Cash Allocation
As ViviCells International follows its natural business cycle, the capital allocation decisions will not magically go away. ViviCells International's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
ViviCells International currently holds 22.31 K in liabilities with Debt to Equity (D/E) ratio of 1.07, which is about average as compared to similar companies. ViviCells International has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ViviCells International's use of debt, we should always consider it together with its cash and equity.ViviCells International Total Assets Over Time
ViviCells International Assets Financed by Debt
The debt-to-assets ratio shows the degree to which ViviCells International uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.ViviCells International Debt Ratio | 19.0 |
ViviCells International Corporate Bonds Issued
Most ViviCells bonds can be classified according to their maturity, which is the date when ViviCells International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ViviCells Long Term Debt
Long Term Debt |
|
About ViviCells Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ViviCells International prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ViviCells shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ViviCells International. By using and applying ViviCells Stock analysis, traders can create a robust methodology for identifying ViviCells entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.05 | 0.04 | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Gross Profit Margin | 0.32 | 0.29 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ViviCells International to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Complementary Tools for ViviCells Stock analysis
When running ViviCells International's price analysis, check to measure ViviCells International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViviCells International is operating at the current time. Most of ViviCells International's value examination focuses on studying past and present price action to predict the probability of ViviCells International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViviCells International's price. Additionally, you may evaluate how the addition of ViviCells International to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |